Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions. The drug fosdenopterin/rcPMP ...

HERVolution Therapeutics ApS, a biotechnology company pioneering human endogenous retrovirus (HERV)-targeting immunotherapies for metabolic diseases, longevity, and oncology, today announced ...

A metric that looks beyond height and weight to underlying biological markers of metabolic health is providing revised estimates of disease risk. According to a new study led by scientists at the ...

The chemicals flowing through your bloodstream tell a story that your DNA alone cannot. They reflect what you eat, how your ...

The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide. This prevalent condition is also linked to other metabolic disorders, including type 2 ...

A significant overlap has been identified in the functionalities of genes associated with immune and metabolic disorders, suggesting a fundamental frameshift is needed in our understanding of the two.

The landscape of renal disease management is undergoing a significant transformation, particularly with the advent of novel therapeutic agents originally ...

Hua Medicine ("the Company", stock code: 2552.HK) presented a series of breakthrough research findings on dorzagliatin (Trade ...